Navigation Links
Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform
Date:8/22/2011

CRANBURY, N.J. and PHILADELPHIA, Aug. 22, 2011 /PRNewswire/ -- Oncobiologics, Inc. and Fox Chase Cancer Center announced today an agreement to co-develop a novel, next-generation bi-specific antibody cancer platform with enhanced therapeutic capabilities against solid tumors. The jointly engineered platform is designed to handle multiple targets, representing a pipeline of promising cancer treatments. This research program is now underway, with preclinical studies expected in Q1-2012 for the first molecule using this platform. Financial terms were not disclosed.

The platform integrates intellectual property originated by both Oncobiologics and Fox Chase. Oncobiologics will play a key role in the discovery program that will be carried out at Fox Chase, and will engage its proof-of-concept engine to develop therapeutic products and move them through clinical trials. The two organizations expect to partner with established pharmaceutical/biopharmaceutical companies for commercialization of drug candidates resulting from the platform, and are actively seeking co-development partners.

"Fox Chase is excited about taking this important step in jointly developing a unique bi-specific antibody platform with Oncobiologics," says Kurt A. Schwinghammer, Ph.D., Vice President of Research and Development Alliances at Fox Chase Cancer Center. "We have been extremely hopeful about the promise of this therapeutic approach."  

Matt Robinson, Ph.D., the principal investigator at Fox Chase and John Cini, Ph.D., Vice President at Oncobiologics, commented, "We believe this platform can improve cancer therapies by improving tumor delivery, enhancing pharmacokinetics, and providing the opportunity for synergistic bi-specific antibody delivery."

"This is an important milestone in demonstrating our mission to increase the flow of biologic drug candidates to the patients who need them," said Pankaj Mohan, Ph.D., Founder & CEO of Oncobiologics. "Strateg
'/>"/>

SOURCE Oncobiologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Henry Schein Announces $200 Million Increase to Stock Repurchase Program
2. ShangPharma Announces Up to $10 Million Share Repurchase Program
3. Masimo Announces Adoption of Stock Repurchase Program
4. Abaxis Announces Stock Repurchase Program
5. Boston Scientific Announces $1.0B Share Repurchase Program
6. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program
7. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
8. BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
9. China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market
10. TPI Board Reinstates Stock Repurchase Program
11. Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... on December 24, 2014 it closed its previously ... raised approximately $2.3 million in gross proceeds from ... proceeds from the offering to fund its research ...
(Date:12/24/2014)... and FARMINGTON, Conn. , Dec. ... MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific ... significant unmet medical need and commercial potential, today ... placement of 2,050,000 shares of its common stock ... of its common stock.  Funds under the management ...
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical ... company engaged primarily in the development of brachytherapy ... applications, today announced that it has filed a ... and Drug Administration ("FDA") for marketing clearance for ... 513(f)(2) of the U.S. Food, Drug and Cosmetic ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... 2010 ACCESS PHARMACEUTICALS, INC. ... ACCP ), a biopharmaceutical company leveraging its proprietary drug-delivery ... supportive care and diabetes, announced that it will be ... Technology Meeting, entitled, "Preclinical Studies with Cobalamin™ Nanoparticles for ...
... NVAX ) a clinical-stage biopharmaceutical company, announced today ... Novavax will be presenting at the Lazard 7th Annual Healthcare ... 2010 at 1:10pm local time at the St. Regis Hotel, ... can be accessed via the Company website at www.novavax.com ...
Cached Medicine Technology:Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting on November 11-13, 2010 2Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting on November 11-13, 2010 3
(Date:12/24/2014)... 2014 The federal court overseeing ... blood thinner caused life-threatening episodes of internal bleeding ... for the proceeding, Bernstein Liebhard LLP reports. According ... plans to select lawyers to serve as Liaison ... appointing a Plaintiffs’ Steering Committee, which will coordinate ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Mike ... sat down with Derek Fenwick, PT, MBA, GCS, ... that will stem from the passing of the ... (IMPACT Act). In this taping of the Infinicast, the ... XVIII of the Social Security Act to standardize post-acute ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- Hepatitis C infection does not ... a new study. Treatment advances have made it possible ... develop memory and thinking problems, mood swings and other types ... It,s believed that long-term infections with other viruses -- ... the brain. One of the prime suspects has been the ...
(Date:12/24/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... start smoking or drinking with each additional symptom they ... new research suggests. "Our findings underscore the ... use as [these] children approach adolescence," said study author ... Group, which is part of Cincinnati Children,s Hospital. "This ...
(Date:12/24/2014)... For chic ladies, new fashionable outfits are necessary when heading ... Wish List, Angeldress.co.uk has chosen some of their ... holiday wardrobe by launching a promotion on its cheap clothes ... of 80% off, like a cheap suit. , “All items ... wedding dresses are among the hottest items in the global ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2
... 2009 Inuit children have the highest rate of ... but new research shows that lowering risk factors though ... improve health for Inuit children and lower health care ... conducted by Dr. Anna Banerji, a pediatric infectious disease ...
... Elimination of funding for the Governor,s Office of ... budget plan would end a wide range of critical ... cost increases, improving quality of care and expanding access, ... years the small "think tank" office has been working ...
... 21 Mayo Clinic researchers have found that bipolar ... as diabetes, depression, asthma or coronary artery disease. These ... claim costs. Specialty care costs (the costs of seeing ... for bipolar patients. Results of this review are being ...
... Wash., May 21 Advana Science ( www.advanascience.com ... in Alzheimer,s disease, has been named scientific advisor to the ... (Volume 16, Issue 3), Dr. Smith was ranked third ... in March 2009. Dr. Smith brings over 20 years ...
... of Alcohol Outlets are More Likely to Contain ... 21 Communities containing larger numbers of stores ... levels of underage alcohol access, according to a ... Center of the Pacific Institute for Research and ...
... in Sydney and Boston believe they may have identified a ... a very troublesome problem for people with diabetes. , The ... blood sugar (glucose) levels fall, the liver makes and releases ... liver doesn,t stop making sugar when it should, so blood ...
Cached Medicine News:Health News:First of its kind study identifies risk factors for LRTIs in Inuit children 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 4Health News:Specialty Care Costs for Patients With Bipolar Disorder Are Higher Than Diabetes and Other Chronic Diseases 2Health News:Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science 2Health News:Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science 3Health News:Communities Containing More Alcohol Outlets Show Increased Underage Alcohol Access 2Health News:Communities Containing More Alcohol Outlets Show Increased Underage Alcohol Access 3Health News:Regulating the sugar factory in diabetes 2
... consists of a 5-megapixel color matrix ... colors, camera control unit with a ... crystal clear LCD display monitor. PC/Mac ... for live image displays and camera ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
... for Geometric Data Hemastainer. Formulated ... are quality control tested on ... proper staining and absence of ... for a minimum of eight ...
Medicine Products: